Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eiger BioPharmaceuticals ...

    NASDAQ: EIGR · Real-Time Price · USD
    1.73
    0.00 (0.29%)
    At close: Apr 03, 2024, 3:59 PM

    Eiger BioPharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 15.77M 13.48M 12.14M
    Cost of Revenue
    		 24K 1.84M 745K
    Gross Profit
    		 15.75M 11.65M 11.4M
    Operating Income
    		 -71.79M -92.74M -76.94M
    Interest Income
    		 2.21M 1.08M 158K
    Pretax Income
    		 -74.96M -96.75M -33.85M
    Net Income
    		 -74.96M -96.78M -33.92M
    Selling & General & Admin
    		 25.2M 29.11M 23.9M
    Research & Development
    		 62.33M 75.28M 64.44M
    Other Expenses
    		 n/a -963K n/a
    Operating Expenses
    		 87.53M 104.39M 88.34M
    Interest Expense
    		 5.47M 4.13M 3.56M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 87.56M 106.22M 89.08M
    Income Tax Expense
    		 6K 23K 64K
    Shares Outstanding (Basic)
    		 1.48M 1.39M 34.63M
    Shares Outstanding (Diluted)
    		 1.48M 1.39M 34.63M
    EPS (Basic)
    		 -50.78 -69.74 -0.98
    EPS (Diluted)
    		 -50.78 -69.74 -0.98
    EBITDA
    		 -68.74M -92.62M -76.94M
    EBIT
    		 -69.49M -92.62M -30.29M
    Depreciation & Amortization
    		 750K 119K 46.65M

    Add to Watchlist